Biotech Venture Capitalists Defy Skeptics with Vaccine Investments

Biotech venture capitalists are contrarians who believe now is the time to invest in vaccines. The pandemic accelerated the development of Covid-19 vaccines by Moderna, BioNTech, and Pfizer, leading to significant stock gains for the three companies. Despite the pandemic's impact on the biotech industry, these investors see potential in vaccines and are taking a contrarian approach to investing.